Related Experiment Videos

Periorbital cellulitis: a comparison of different treatment regimens

G Kanra1, G Seçmeer, E N Gönç

  • 1Department of Pediatric Infectious Diseases, Hacettepe University Children's Hospital, Ankara, Turkey.

Acta Paediatrica Japonica : Overseas Edition
|August 1, 1996
PubMed

Insights

Sinusitis is the leading cause of periorbital cellulitis in children. Sulbactam-ampicillin (SAM) demonstrated a lower recurrence rate compared to penicillin plus chloramphenicol, suggesting it as a preferred first-line treatment.

Area of Science:

  • Pediatric infectious diseases
  • Ophthalmology

Background:

  • Periorbital cellulitis is a common infection in children.
  • Identifying causative factors and optimal treatment is crucial for effective management.

Purpose of the Study:

  • To determine the primary causes of periorbital cellulitis in a pediatric cohort.
  • To evaluate the efficacy of different antimicrobial regimens for treating periorbital cellulitis.

Main Methods:

  • Retrospective investigation of 69 children (1.5-16 years) with periorbital cellulitis.
  • Analysis of associated conditions, predisposing factors, and microbial isolates.
  • Comparison of treatment outcomes between penicillin plus chloramphenicol and sulbactam-ampicillin (SAM) regimens.

Main Results:

  • Sinusitis was the most frequent associated condition (43%), followed by trauma (25%).
  • Staphylococcus aureus was the predominant pathogen (74% of isolates).
  • SAM showed a lower recurrence rate (3%) compared to penicillin plus chloramphenicol (17%).

Conclusions:

  • Sinusitis and trauma are key predisposing factors for pediatric periorbital cellulitis.
  • Sulbactam-ampicillin (SAM) is a potentially superior first-line treatment due to its broad spectrum and lower recurrence rates.
  • SAM offers a safe and effective option for periorbital cellulitis across various etiologies and age groups.

Related Concept Videos